PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34896433-0	2022	Alisertib shows negligible potential for perpetrating pharmacokinetic drug-drug interactions on ABCB1, ABCG2 and cytochromes P450, but acts as dual-activity resistance modulator through the inhibition of ABCC1 transporter.	MLN 8237	0-9	ATP binding cassette subfamily C member 1	Homo sapiens	204-209	
34896433-3	2022	In accumulation assays, alisertib potently inhibited ABCC1 transporter, but not ABCB1 or ABCG2.	MLN 8237	24-33	ATP binding cassette subfamily C member 1	Homo sapiens	53-58	
34896433-6	2022	Drug combination studies revealed the capability of alisertib to synergistically antagonize ABCC1-mediated resistance to daunorubicin.	MLN 8237	52-61	ATP binding cassette subfamily C member 1	Homo sapiens	92-97